Boosting Europe’s Sovereignty in Technology by driving Photonics from Research to Market – Photonics21
BestPhorm21 will provide the decisive support to Horizon Europe’s “Photonics Partnership”, which is currently established between the EU Commission and Photonics21, to stimulate the growth of the European photonics industry. The project is led by the Photoncs21 Secretariat, VDITZ, in partnership with 14 National Technology Platforms, representing Europe’s photonics industry, Research and Technology Organisations (RTOs) and clusters. BestPhorm21 will develop a community driven European photonics industrial strategy and roadmap, engaging over 3,000 experts from industry and academia, that will guide Horizon Europe and industrial investments in R&D and advanced manufacturing. BestPhorm21 thus makes a significant contribution to increasing European technological sovereignty in a key digital technology such as photonics. It will furthermore establish new strategic value chains between photonics and end user industries, through the delivery of 7 additional “photonics enabled” end user industry roadmaps. This will be done in close cooperation with the respective industry stakeholders organsiations, more than 700 experts from both the photonics and end-user industries will be involved.
Partner:
- VDI TECHNOLOGIEZENTRUM GMBH
- ASSOCIAZIONE ITALIANA DI ELETTROTECNICA, ELETTRONICA, AUTOMAZIONE, INFORMATICA E TELECOMUNICAZIONI
- PHOTONICS FINLAND
- EKONOMISKA FORENINGEN PHOTONICSWEDEN
- ELLINIKI ENOSI FOTONIKIS ASTIKI MIKERDOSKOPIKI ETAIRIA
- KNOWLEDGE TRANSFER NETWORK LIMITED
- MOKSLINIU TYRIMU IR TECHNOLOGIJU ORGANIZACIJU ASOCIACIJA
- PHOTONICS AUSTRIA – PLATTFORM ZUR FORDERUNG DER OSTERREICHISCHEN INTERESSEN IM BEREICH PHOTONIK
- PHOTONICS FRANCE
- POLSKA PLATFORMA TECHNOLOGICZNA FOTONIKI
- UNIVERSITY COLLEGE CORK – NATIONAL UNIVERSITY OF IRELAND, CORK
- UNIVERSITAT POLITECNICA DE CATALUNYA
- VEREIN SCHWEIZER LASER UND PHOTONIK NETZ
- VERENIGING PHOTONICSNL
- VRIJE UNIVERSITEIT BRUSSEL
Resp. Scientifico: Dr. Toffanin (es. Dr.ssa Leo)
Tipologia: H2020-ICT
Acronimo: BESTPHORM21
Durata: 01/01/2022 – 31/12/2023
